Cargando…

SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1

SMAD4 is a tumour suppressor and an important regulator of tumour immune scape which is downregulated in cholangiocarcinoma (CCA). STING1 is a vital sensing factor of abnormal DNA; however, the correlation between SMAD4 and STING1 and the role of the SMAD4‐STING1 interaction in the progression of CC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, An‐da, Zhao, Li‐ming, Sheng, Guo‐li, Zhang, Ge‐ning, Tang, Yong‐chang, Li, Kang‐shuai, Zhang, Zong‐li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468663/ https://www.ncbi.nlm.nih.gov/pubmed/37488750 http://dx.doi.org/10.1111/jcmm.17857

Ejemplares similares

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma
por: Zhao, Li-ming, et al.
Publicado: (2023)

Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling
por: Xu, Yun‐Fei, et al.
Publicado: (2018)

Genome mining and biosynthesis of kitacinnamycins as a STING activator
por: Shi, Jing, et al.
Publicado: (2019)

The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma
por: Zhang, Ke-jun, et al.
Publicado: (2010)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers
por: Li, Yun-cheng, et al.
Publicado: (2022)

SMAD4 Y353C promotes the progression of PDAC
por: Wang, Zusen, et al.
Publicado: (2019)

Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression
por: Wang, Tingjie, et al.
Publicado: (2022)

Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma
por: Xie, Nan, et al.
Publicado: (2017)

YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
por: Zhou, Shuai, et al.
Publicado: (2021)

Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
por: Li, Kai, et al.
Publicado: (2017)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Long Noncoding RNA GAS5 Accelerates Cholangiocarcinoma Progression by Regulating hsa-miR-1297
por: Li, Qian, et al.
Publicado: (2021)

microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
por: Qiao, Pengfei, et al.
Publicado: (2015)

STING modulators: Predictive significance in drug discovery
por: Cui, Xiangling, et al.
Publicado: (2019)

BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways
por: Jiao, Chen Yu, et al.
Publicado: (2021)

Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?
por: Wang, Jing, et al.
Publicado: (2020)

Gelsevirine is a novel STING-specific inhibitor and mitigates STING-related inflammation in sepsis
por: Chen, Yuhong, et al.
Publicado: (2023)

Macrophages-aPKC(ɩ)-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma
por: Yang, Tao, et al.
Publicado: (2022)

miR-186 Suppresses the Progression of Cholangiocarcinoma Cells Through Inhibition of Twist1
por: Zhang, Ming, et al.
Publicado: (2019)

STING1 in sepsis: Mechanisms, functions, and implications
por: Zhang, Ruo-Xi, et al.
Publicado: (2022)

Progress of cGAS-STING signaling in response to SARS-CoV-2 infection
por: Wu, Yaru, et al.
Publicado: (2022)

Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway
por: Zhang, Xiao-ming, et al.
Publicado: (2020)

Inhibition mechanism of lung cancer cell metastasis through targeted regulation of Smad3 by miR-15a
por: Guo, Shuai, et al.
Publicado: (2020)

PRDX6 knockout restrains the malignant progression of intrahepatic cholangiocarcinoma
por: Li, Hong, et al.
Publicado: (2022)

STING1 in Different Organelles: Location Dictates Function
por: Zhang, Ruoxi, et al.
Publicado: (2022)

The STING1 network regulates autophagy and cell death
por: Zhang, Ruoxi, et al.
Publicado: (2021)

Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients
por: He, Shi-ming, et al.
Publicado: (2011)

Long Noncoding RNA KCNMB2-AS1 Promotes SMAD5 by Targeting miR-3194-3p to Induce Bladder Cancer Progression
por: Chen, Yong-Sheng, et al.
Publicado: (2021)

Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation
por: Huang, Lining, et al.
Publicado: (2020)

The Human-Specific STING Agonist G10 Activates Type I Interferon and the NLRP3 Inflammasome in Porcine Cells
por: Ming, Sheng-Li, et al.
Publicado: (2020)

Exosomal microRNA-23a-3p contributes to the progression of cholangiocarcinoma by interaction with Dynamin3
por: Ni, Qingfeng, et al.
Publicado: (2022)

Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression
por: Li, Zhang, et al.
Publicado: (2022)

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity
por: Xia, Meng, et al.
Publicado: (2017)

Macroscopic hematuria in wasp sting patients: a retrospective study
por: Wang, Maohe, et al.
Publicado: (2021)

Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway
por: Yuan, Xingxing, et al.
Publicado: (2018)

Aspirin inhibits endometrial fibrosis by suppressing the TGF-β1-Smad2/Smad3 pathway in intrauterine adhesions
por: Zhang, Zihui, et al.
Publicado: (2020)

LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma
por: Shen, Sheng, et al.
Publicado: (2019)

Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256
por: Chen, Shaoyi, et al.
Publicado: (2022)

Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
por: Chen, Hua-Dong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_99pcbc582jofm5hj5vmaio6oi4